Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Rolls-Royce Holdings | 7.24% | $54.62M | £92.26B | 103.42% | 71 Outperform | |
| Babcock International | 5.10% | $38.47M | £6.05B | 143.20% | 67 Neutral | |
| Prosus | 3.59% | $27.06M | €114.59B | 46.57% | 77 Outperform | |
| Teva Pharmaceutical | 3.26% | $24.61M | $34.30B | 41.79% | 63 Neutral | |
| Societe Generale | 2.80% | $21.09M | €42.64B | 147.42% | 72 Outperform | |
| Siemens Energy | 2.77% | $20.87M | $119.43B | 162.40% | 76 Outperform | |
| Companhia De Saneamento | 2.71% | $20.42M | $16.56B | 74.53% | 71 Outperform | |
| Brookfield Corporation | 2.61% | $19.68M | $111.18B | 20.41% | 65 Neutral | |
| Sony Group | 2.53% | $19.10M | $159.72B | 24.15% | 75 Outperform | |
| Novo Nordisk | 2.18% | $16.46M | $215.79B | -54.92% | 73 Outperform |